Drugs / Disopiramide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06555237 Comparator | Aug 2024 → Aug 2026 overdue | Noonan syndrome | Medical University of Warsaw | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Disopiramide | “Disopiramide and Beta blockers orally” NCT06555237 ↗ |
| Modality | Small molecule | — CHEMBL269362 ↗ |
| Route | Oral | “Disopiramide and Beta blockers orally” NCT06555237 ↗ |